Zamansky & Associates LLC Investigates Rockwell Medical Technologies for Possible Federal Securities Laws Violations

Share Article

Zamansky & Associates LLC notifies all investors in Rockwell Medical Technologies Inc., the biopharmaceutical company, for possible violations of federal securities laws over its publis statements and representations about the progress of Soluble Ferric Pyrophosphate (“SFP”), an experimental iron-therapy drug intended to treat iron-deficiency.

Zamansky & Associates LLC notifies all investors in Rockwell Medical Technologies Inc. (“Rockwell Medical”), the Wixom, Michigan biopharmaceutical company for possible violations of federal securities laws. The investigation concerns Rockwell Medical’s public statements and representations about the progress of Soluble Ferric Pyrophosphate (“SFP”), an experimental iron-therapy drug intended to treat iron-deficiency.

On March 6, 2012, a lawsuit filed by a former employee of Rockwell Medical against the company was removed to federal court. The case is Richard Yocum, M.D. v. Rockwell Medical Technologies Inc. et al., Case No. 12-CV-568 (MMD) in the United States District Court, Southern District of California. In his Complaint, Yocum alleges that he was Rockwell Medical’s Vice President of Drug Development and Medical Affairs. He further alleges that he was terminated in retaliation for opposing Rockwell Medical misrepresentations to investors in public statements about the progress of SFP’s Phase III clinical trials and its efforts to obtain FDA approval. His complaint alleges wrongful termination in violation of public policy and seeks compensation owed to him as well as damages.

In view of these allegations, Zamansky has launched an investigation on behalf of the investors in Rockwell Medical stock. According to Jake Zamansky, any inaccurate information concerning the progress of SFP’s Phase III clinical trials or FDA approval would be of material concern to any investor or shareholder.

What Rockwell Medical Technologies Investors Can Do

If you are a shareholder and would like to discuss your legal rights, you may, without obligation or cost to you, email jake(at)zamansky(dot)com or call the law firm at (212) 742-1414.

About Zamansky & Associates LLC

Zamansky & Associates LLC is one of the leading law firms specializing in securities fraud and financial services arbitration and class action litigation. We represent both individual and institutional investors. Our practice is nationally recognized for our ability to aggressively prosecute cases and recover losses.

To learn more about Zamansky, please visit our website, http://www.zamansky.com.

Contacts

Zamansky & Associates, LLC
50 Broadway - 32nd Floor
New York, NY 10004
Jake Zamansky, 212-742-1414
jake(at)zamansky(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jacob Zamansky
Visit website